Delivery Order SPE2DB20D3103-SPE2DB23FM8G4

Award Date 3/21/23
Potential Completion Date 3/22/23
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets. The $6,230.85 firm-fixed-price contract has an ultimate completion date of March 28, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,463.27, is for the delivery of Isentress 400 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of May 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,236.60 firm fixed-price delivery order covers the procurement of Isentress 400mg tablets, with an ultimate completion date of May 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets. The contract has a ceiling value of $10,631.13 and runs through January 17, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,566,357,431 units of the medication Isentress 400 mg tablets. The contract has a ceiling value of $2,649.95 and an ultimate completion date of November 7, 2024. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Isentress 400 mg tablets and has an ultimate completion date of April 18, 2024. The contract ceiling value is $1,386.24. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, serving agencies such as the Department of Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Isentress 400 mg tablets. The $3,067.56 firm fixed-price delivery order contract has a completion date of February 10, 2025. AmerisourceBergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,668.50, is for the delivery of Isentress 400 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of December 12, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,435.54 fixed-price contract is for the delivery of Isentress 400 mg tablets, a medication used to treat HIV. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,216.35 firm fixed price delivery order is for the supply of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM8G4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets. The contract has a ceiling value of $4,156.35 and runs through March 2023.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical commodities.

This delivery order does not have a set-aside designation, indicating open competition. The award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.

Generated 2/27/25, 10:06 AM